Display options
Share it on

Gastroenterol Res Pract. 2018 Aug 12;2018:6417526. doi: 10.1155/2018/6417526. eCollection 2018.

On-Demand Therapy with Proton Pump Inhibitors for Maintenance Treatment of Nonerosive Reflux Disease or Mild Erosive Esophagitis: A Systematic Review and Meta-Analysis.

Gastroenterology research and practice

Zubair Khan, Yaseen Alastal, Muhammad Ali Khan, Mohammad Saud Khan, Basmah Khalil, Shreesh Shrestha, Faisal Kamal, Ali Nawras, Colin W Howden

Affiliations

  1. Division of Gastroenterology and Hepatology, University of Toledo Medical Center, Toledo, OH, USA.
  2. Division of Gastroenterology and Hepatology, The University of Tennessee Health Science Center, Memphis, TN, USA.

PMID: 30158966 PMCID: PMC6109549 DOI: 10.1155/2018/6417526

Abstract

BACKGROUND: Proton pump inhibitors (PPIs) are widely used for the long-term management of gastroesophageal reflux disease (GERD). However, concerns about the cost and/or inconvenience of continuous maintenance PPI treatment have led to the evaluation of various alternative approaches.

AIM: To assess the effectiveness of on-demand PPI therapy in the maintenance treatment of nonerosive reflux disease (NERD) or mild erosive esophagitis (EE).

METHODS: We searched MEDLINE, EMBASE, Web of Science, and Cochrane Library from inception until October 2, 2017, for randomized controlled trials (RCTs) comparing on-demand PPI versus placebo or daily PPI in the management of NERD or mild EE (Savary-Miller grade 1). Discontinuation of therapy during the trial was used as a surrogate for patient dissatisfaction and failure of symptomatic control. We calculated pooled odds ratios (OR) to evaluate the efficacy of on-demand PPI treatment. Separate analyses were conducted for studies comparing on-demand PPI with daily PPI and with placebo. Subgroup analysis was done based on NERD studies alone and on studies of both NERD and mild EE. These were analyzed using a random effects model.

RESULTS: We included 10 RCTs with 4574 patients. On-demand PPI was superior to daily PPI (pooled OR = 0.50; 95% confidence interval (CI) = 0.35, 0.72). On subgroup analysis in NERD patients only, pooled OR was 0.44 (0.29, 0.66). In studies including patients with NERD and mild EE, pooled OR was 0.76 (0.36, 1.60). For studies comparing on-demand PPI with placebo, pooled OR was 0.21 (0.15, 0.29); subgroup analyses of studies evaluating NERD only and studies conducted in NERD and mild EE showed similar results (pooled OR was 0.22 (0.13, 0.36) and 0.18 (0.11, 0.31), resp.).

CONCLUSIONS: On-demand PPI treatment is effective for many patients with NERD or mild EE. Although not FDA-approved, it may be adequate for those patients whose symptoms are controlled to their satisfaction.

References

  1. Aliment Pharmacol Ther. 1999 Jul;13(7):907-14 - PubMed
  2. Aliment Pharmacol Ther. 2004 Jul 15;20(2):181-8 - PubMed
  3. Cochrane Database Syst Rev. 2006 Jul 19;(3):CD002095 - PubMed
  4. Digestion. 2008;78 Suppl 1:6-10 - PubMed
  5. Aliment Pharmacol Ther. 2004 Sep 15;20(6):657-65 - PubMed
  6. BMC Gastroenterol. 2016 Apr 14;16:48 - PubMed
  7. Cochrane Database Syst Rev. 2017 Mar 16;3:CD011969 - PubMed
  8. Therap Adv Gastroenterol. 2012 Jul;5(4):219-32 - PubMed
  9. Clin Gastroenterol Hepatol. 2007 Jan;5(1):17-26 - PubMed
  10. Lancet. 2006 Jun 24;367(9528):2086-100 - PubMed
  11. Am J Gastroenterol. 2007 Mar;102(3):642-53 - PubMed
  12. Dig Dis Sci. 2000 Apr;45(4):809-18 - PubMed
  13. BMJ. 2009 Jul 21;339:b2700 - PubMed
  14. Curr Ther Res Clin Exp. 2005 Jul;66(4):345-63 - PubMed
  15. BMJ. 2004 Jun 19;328(7454):1490 - PubMed
  16. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003245 - PubMed
  17. J Gastroenterol Hepatol. 2002 Sep;17(9):949-54 - PubMed
  18. Am J Gastroenterol. 2006 Nov;101(11):2457-62 - PubMed
  19. Br J Gen Pract. 1999 Jun;49(443):451-3 - PubMed
  20. Eur J Gastroenterol Hepatol. 2002 Aug;14(8):857-63 - PubMed
  21. Aliment Pharmacol Ther. 2001 Mar;15(3):347-54 - PubMed
  22. Scand J Gastroenterol. 2002 Jun;37(6):642-7 - PubMed
  23. Clin Gastroenterol Hepatol. 2004 Aug;2(8):656-64 - PubMed
  24. Clin Gastroenterol Hepatol. 2007 Jun;5(6):690-5 - PubMed
  25. Am J Gastroenterol. 2006 Aug;101(8):1900-20; quiz 1943 - PubMed
  26. Aliment Pharmacol Ther. 2006 Jul 1;24(1):33-45 - PubMed
  27. Scand J Gastroenterol. 2014 Apr;49(4):409-17 - PubMed
  28. Hepatogastroenterology. 2013 Jul-Aug;60(125):1077-82 - PubMed
  29. Am J Gastroenterol. 2006 Sep;101(9):2128-38 - PubMed
  30. Aliment Pharmacol Ther. 2003 Oct 15;18(8):767-76 - PubMed
  31. Aliment Pharmacol Ther. 2007 Jul 15;26(2):195-204 - PubMed
  32. Aliment Pharmacol Ther. 2005 Aug 1;22(3):183-91 - PubMed
  33. Eur J Gastroenterol Hepatol. 2005 Sep;17(9):935-41 - PubMed
  34. Gastroenterology. 2001 Nov;121(5):1095-100 - PubMed
  35. Digestion. 2005;72(2-3):76-85 - PubMed
  36. Am J Gastroenterol. 2004 May;99(5):946-9 - PubMed
  37. Aliment Pharmacol Ther. 2011 Jan;33(2):213-24 - PubMed
  38. Br J Gen Pract. 1999 Jun;49(443):463-4 - PubMed

Publication Types